Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.161 CHF
−11.19 M CHF
1.67 B CHF
13.07 M
About REDCARE PHARMACY N.V.
Sector
Industry
CEO
Olaf Heinrich
Website
Headquarters
Sevenum
Founded
2021
ISIN
NL0012044747
FIGI
BBG00LVGDWQ0
Redcare Pharmacy NV engages in the business of prescription and non-prescription pharmaceuticals; beauty and personal care (BPC) products; and food supplements. It operates under the DACH and International segments. The DACH segment includes medications and pharmacy-related BPC products sold to customers in Germany, Austria, and Switzerland. The International segment focuses on Belgium, the Netherlands, France, and Italy. The company was founded by Frank Köhler, Stephan Weber, and Marc Fischer in January 2001 and is headquartered in Sevenum, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SAE is 134.275 CHF — it has decreased by −2.10% in the past 24 hours. Watch REDCARE PHARMACY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange REDCARE PHARMACY stocks are traded under the ticker SAE.
SAE stock has fallen by −11.92% compared to the previous week, the month change is a 0.28% rise, over the last year REDCARE PHARMACY has showed a 21.59% increase.
We've gathered analysts' opinions on REDCARE PHARMACY future price: according to them, SAE price has a max estimate of 190.01 CHF and a min estimate of 79.96 CHF. Watch SAE chart and read a more detailed REDCARE PHARMACY stock forecast: see what analysts think of REDCARE PHARMACY and suggest that you do with its stocks.
SAE stock is 2.14% volatile and has beta coefficient of 0.86. Track REDCARE PHARMACY stock price on the chart and check out the list of the most volatile stocks — is REDCARE PHARMACY there?
Today REDCARE PHARMACY has the market capitalization of 2.75 B, it has decreased by −5.37% over the last week.
Yes, you can track REDCARE PHARMACY financials in yearly and quarterly reports right on TradingView.
REDCARE PHARMACY is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
SAE earnings for the last quarter are −0.39 CHF per share, whereas the estimation was −0.62 CHF resulting in a 37.23% surprise. The estimated earnings for the next quarter are −0.85 CHF per share. See more details about REDCARE PHARMACY earnings.
REDCARE PHARMACY revenue for the last quarter amounts to 542.30 M CHF, despite the estimated figure of 542.45 M CHF. In the next quarter, revenue is expected to reach 643.74 M CHF.
SAE net income for the last quarter is −6.52 M CHF, while the quarter before that showed −4.11 M CHF of net income which accounts for −58.75% change. Track more REDCARE PHARMACY financial stats to get the full picture.
No, SAE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 2.08 K employees. See our rating of the largest employees — is REDCARE PHARMACY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REDCARE PHARMACY EBITDA is 27.95 M CHF, and current EBITDA margin is 2.25%. See more stats in REDCARE PHARMACY financial statements.
Like other stocks, SAE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REDCARE PHARMACY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REDCARE PHARMACY technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REDCARE PHARMACY stock shows the strong buy signal. See more of REDCARE PHARMACY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.